COST-EFFECTIVENESS OF POLYPILL TREATMENT IN HIGH-RISK HYPERTENSIVE SUBJECTS WITH HYPER-CHOLESTEROLAEMIA. Mazza A, Bregola G, Cavazzin E, Dell'avvocata F, et al. J Hypertens 2022;40.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mazza A, Bregola G, Cavazzin E, Dell'avvocata F, et al. COST-EFFECTIVENESS OF POLYPILL TREATMENT IN HIGH-RISK HYPERTENSIVE SUBJECTS WITH HYPER-CHOLESTEROLAEMIA. J Hypertens 2022;40.
PMID: 36027190